PT Medco Energi Internasional (MEDC) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
1 May, 2026Executive summary
Q1 2026 production reached 169 mboepd, up 18% year-over-year, with oil & gas, power, and mining segments all contributing to growth.
Net income surged 282% year-over-year to USD 67.4 million, mainly due to contributions from Amman Mineral and higher oil prices.
EBITDA rose to USD 351 million, reflecting a 5.7% year-over-year increase, driven by higher revenues and disciplined cost management.
Amman Mineral Internasional contributed USD 34 million in net income in Q1 2026.
Power sales increased, supported by renewable capacity expansion and successful project completions.
Financial highlights
Revenue grew 19.2% year-over-year to USD 668 million, with oil & gas revenue up 21% and power revenue down 2% despite higher sales volume.
Gross profit remained stable at USD 232 million, with a margin of 34.7%.
Operating cash flow increased 29.7% year-over-year to USD 273 million.
Consolidated gross debt reduced by USD 126 million from FY 2025, with RG net debt/EBITDA improving to 1.7x.
Cash and cash equivalents stood at USD 598 million, reflecting ongoing debt management.
Outlook and guidance
2026 production guidance maintained at 165–170 mboepd for oil & gas and 4,550 GWh for power.
Capex guidance for 2026 set at USD 400–430 million for oil & gas and USD 15 million for power.
Cash cost expected to remain below USD 10 per boe.
Continued focus on portfolio enhancements, project ramp-ups, and further debt reduction.
Latest events from PT Medco Energi Internasional
- Met guidance with stable EBITDA, portfolio growth, and record shareholder returns.MEDC
Q4 20259 Apr 2026 - EBITDA dropped 4% to $623M in 1H 2025; major Corridor PSC stake acquired.MEDC
Q2 20258 Jan 2026 - Stable EBITDA and higher dividends offset lower net income amid major asset acquisitions.MEDC
Q3 20258 Jan 2026 - Diversified energy operations, robust growth, and ESG leadership drive superior shareholder returns.MEDC
CMD 2024 Presentation4 Jul 2025 - Q1 EBITDA rose to $332mn, with strong operations, liquidity, and key project milestones achieved.MEDC
Q1 202517 Jun 2025 - Net income and revenue rose in 9M 2024, supported by asset optimization and strong cash flow.MEDC
Q3 202413 Jun 2025 - Net income surged 68.9% to US$201mn on higher revenue, asset sales, and Oman gain.MEDC
Q2 202413 Jun 2025 - Record 2024 results with net income up 11% and strong growth across all segments.MEDC
Q4 20245 Jun 2025